Continuing a four-year trend, total U.S. venture capital investment in health care surged in 2018, reaching a new all-time high of $9.6 billion, according to Silicon Valley Bank's (SVB) Trends in … [Read more...]
Investment Trends: Dx/Tools Venture Capital Keeps Flowing Despite Decline in Early-Stage Investment
Investment Trends: Venture Capitalists Remain High on Healthcare
Healthcare startups remain highly attractive to venture capitalists drawing $10.6 billion in investments in the first half of 2018, the most of any industry sector other than internet companies and … [Read more...]
Theranos & Its CEO Settle Stock Fraud Charges with SEC
Seven years ago, Theranos was a $9 billion dynamo seemingly on the precipice of blowing the blood testing market wide open. Today, the company and its CEO and founder, Elizabeth Holmes, are a … [Read more...]
The Year in Dx VC Investment: Dx/Tools Outperforms Health Care & Liquid Biopsy/AI/ Informatics Outperforms Dx/Tools
In a year that witnessed venture capital health care investment reaching an all-time high, diagnostics/tools (Dx/Tools) companies made out particularly well, according to Silicon Valley Banks' … [Read more...]
Industry Trends: New Report Sheds Light on DX Tech Capital Flows
The health care industry has raised $5 billion in venture fund investment in the first half of 2017 and is well on pace to smash the single year record of $7.5 billion set in 2015, according to … [Read more...]
Grifols Takes 20 percent Stake in Singulex
Grifols, the Spanish biotech firm, has taken a 20 percent stake in a California- based laboratory for $50 million. The deal is among the latest involving overseas businesses taking stakes in … [Read more...]
Quanterix Raises $46 Million to Fuel Expansion of Clinical Diagnostics
By Stephanie Murg, Managing Director, G2 Intelligence A fresh infusion of capital is set to fuel continued growth at Quanterix Corporation (Lexington, Mass.), which specializes in "high-definition … [Read more...]
AltheaDX Raises $30 Million, Announces New Tests
AltheaDX, a California-based lab that focuses on pharmacogenetic testing, has raised $30 million in a third round of financing. The money comes from several investors, including WUXi Healthcare … [Read more...]
Laboratory M&A in 2015: Flat but With Possibilities Moving Forward
When it came to mergers and acquisitions in the laboratory arena, 2015 has proven to be pretty much more of the same. Altogether, there were 29 transactions announced during the 2015 calendar year, … [Read more...]
AltheaDX Raises $30 Million, Announces New Tests
AltheaDX, a California-based lab that focuses on pharmacogenetic testing, has raised $30 million in a third round of financing. The money comes from several investors, including WUXi Healthcare … [Read more...]